03668nam 22006135 450 991036994070332120200706055535.03-030-31113-910.1007/978-3-030-31113-1(CKB)4100000009844710(DE-He213)978-3-030-31113-1(MiAaPQ)EBC5979124(PPN)253181410(EXLCZ)99410000000984471020191114d2020 u| 0engurnn|008mamaatxtrdacontentcrdamediacrrdacarrierAtlas of Response to Immunotherapy /edited by Egesta Lopci, Stefano Fanti1st ed. 2020.Cham :Springer International Publishing :Imprint: Springer,2020.1 online resource (VIII, 127 p. 111 illus., 100 illus. in color.) 3-030-31112-0 PART I BRIEF INTRODUCTION: Immunotherapy in oncology -- Evolution of response criteria -- Part II DIESEASE-ORIENTED APPLICATIONS: CNS -- Thorax -- Melanoma -- Gastrointestinal -- Genitourinary -- Hematologic -- Other tumor types -- PART III PITFALLS AND IMMUNE-RELATED ADVERSE EVENTS (IrAEs) PART IV IMMUNO-PET.This atlas is a concise but comprehensive guide to the diverse patterns of response to immunotherapy as observed on Positron Emission Tomography/Computed Tomography (PET/CT) and other conventional imaging modalities, including CT and Magnetic Resonance Imaging (MRI). The purpose for this publication is to fill the gap between the growing clinical relevance and utilization of immunotherapy in medical oncology, mainly based on checkpoint inhibitors, and the need for experienced imagers with reliable tools assessing response to treatment. A series of disease-oriented chapters will present the imaging findings during immunotherapy in the major oncological settings, with helpful comparison of functional (PET/CT) and morphological (CT/MRI) patterns of response in individual cases. To complete the atlas, a dedicated chapter will focus on major pitfalls and immune-related adverse events (irAEs) affecting image interpretation during the course of immunotherapy. The concluding chapter will lastly examine the available data and potential developments of immuno-PET, which is considered as the novel frontier of research in this oncological scenario. The atlas will be of high value for radiologists and nuclear medicine specialists at all levels of experience.Nuclear medicineOncology  ImmunologyRadiologyNuclear Medicinehttps://scigraph.springernature.com/ontologies/product-market-codes/H29048Oncologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H33160Immunologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B14000Diagnostic Radiologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H29013Nuclear medicine.Oncology  .Immunology.Radiology.Nuclear Medicine.Oncology.Immunology.Diagnostic Radiology.616.07548616.079Lopci Egestaedthttp://id.loc.gov/vocabulary/relators/edtFanti Stefanoedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910369940703321Atlas of Response to Immunotherapy2210788UNINA